Celgene Corp (NASDAQ:CELG)

121.53
Delayed Data
As of Feb 27
 -1.82 / -1.48%
Today’s Change
66.85
Today|||52-Week Range
125.45
+8.64%
Year-to-Date

Today’s Trading

Previous close123.35
Today’s open122.81
Day’s range120.77 - 123.14
Volume4,288,968
Average volume (3 months)5,588,293
Market cap$97.3B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+30.02%
Earnings growth (next 5 years)+25.30%
Revenue growth (last year)+18.31%
P/E ratio50.8
Price/Sales11.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.22+0.46%
ABBVAbbVie-0.02-0.03%
BMYBristol-Myers Squibb-0.54-0.88%
AZNAstraZeneca-0.11-0.16%
Data as of 4:07pm ET, 02/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.07
Annual revenue (last year)$7.7B
Annual profit (last year)$2.0B
Net profit margin26.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account